227 related articles for article (PubMed ID: 27279908)
1. Synthesis and Preclinical Evaluation of Sulfonamido-based [(11)C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase.
Wang L; Mori W; Cheng R; Yui J; Hatori A; Ma L; Zhang Y; Rotstein BH; Fujinaga M; Shimoda Y; Yamasaki T; Xie L; Nagai Y; Minamimoto T; Higuchi M; Vasdev N; Zhang MR; Liang SH
Theranostics; 2016; 6(8):1145-59. PubMed ID: 27279908
[TBL] [Abstract][Full Text] [Related]
2. Radiosynthesis and ex vivo evaluation of [(11)C-carbonyl]carbamate- and urea-based monoacylglycerol lipase inhibitors.
Hicks JW; Parkes J; Tong J; Houle S; Vasdev N; Wilson AA
Nucl Med Biol; 2014 Sep; 41(8):688-94. PubMed ID: 24969632
[TBL] [Abstract][Full Text] [Related]
3. Radiosynthesis and evaluation of a novel monoacylglycerol lipase radiotracer: 1,1,1,3,3,3-hexafluoropropan-2-yl-3-(1-benzyl-1H-pyrazol-3-yl)azetidine-1-[
Mori W; Hatori A; Zhang Y; Kurihara Y; Yamasaki T; Xie L; Kumata K; Hu K; Fujinaga M; Zhang MR
Bioorg Med Chem; 2019 Aug; 27(16):3568-3573. PubMed ID: 31278005
[TBL] [Abstract][Full Text] [Related]
4. A Novel Radiotracer for Imaging Monoacylglycerol Lipase in the Brain Using Positron Emission Tomography.
Wang C; Placzek MS; Van de Bittner GC; Schroeder FA; Hooker JM
ACS Chem Neurosci; 2016 Apr; 7(4):484-9. PubMed ID: 26694017
[TBL] [Abstract][Full Text] [Related]
5. First demonstration of in vivo mapping for regional brain monoacylglycerol lipase using PET with [
Yamasaki T; Mori W; Zhang Y; Hatori A; Fujinaga M; Wakizaka H; Kurihara Y; Wang L; Nengaki N; Ohya T; Liang SH; Zhang MR
Neuroimage; 2018 Aug; 176():313-320. PubMed ID: 29738910
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of carbamate derivatives as fatty acid amide hydrolase and monoacylglycerol lipase inhibitors.
Jaiswal S; Gupta G; Ayyannan SR
Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200081. PubMed ID: 35924298
[TBL] [Abstract][Full Text] [Related]
7. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM
J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of minocycline and KML29, a potent inhibitor of monoacylglycerol lipase, in an experimental stroke model: a small-animal positron emission tomography study.
Yamasaki T; Hatori A; Zhang Y; Mori W; Kurihara Y; Ogawa M; Wakizaka H; Rong J; Wang L; Liang S; Zhang MR
Theranostics; 2021; 11(19):9492-9502. PubMed ID: 34646382
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.
Hicks JW; Parkes J; Sadovski O; Tong J; Houle S; Vasdev N; Wilson AA
Nucl Med Biol; 2013 Aug; 40(6):740-6. PubMed ID: 23731552
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
[TBL] [Abstract][Full Text] [Related]
12. Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity.
Zhang L; Butler CR; Maresca KP; Takano A; Nag S; Jia Z; Arakawa R; Piro JR; Samad T; Smith DL; Nason DM; O'Neil S; McAllister L; Schildknegt K; Trapa P; McCarthy TJ; Villalobos A; Halldin C
J Med Chem; 2019 Sep; 62(18):8532-8543. PubMed ID: 31483137
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors.
Kapanda CN; Masquelier J; Labar G; Muccioli GG; Poupaert JH; Lambert DM
J Med Chem; 2012 Jun; 55(12):5774-83. PubMed ID: 22651858
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet.
Terrone G; Pauletti A; Salamone A; Rizzi M; Villa BR; Porcu L; Sheehan MJ; Guilmette E; Butler CR; Piro JR; Samad TA; Vezzani A
Epilepsia; 2018 Jan; 59(1):79-91. PubMed ID: 29171003
[TBL] [Abstract][Full Text] [Related]
15. Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases.
Long JZ; Jin X; Adibekian A; Li W; Cravatt BF
J Med Chem; 2010 Feb; 53(4):1830-42. PubMed ID: 20099888
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048).
Aaltonen N; Kedzierska E; Orzelska-Górka J; Lehtonen M; Navia-Paldanius D; Jakupovic H; Savinainen JR; Nevalainen T; Laitinen JT; Parkkari T; Gynther M
J Pharmacol Exp Ther; 2016 Oct; 359(1):62-72. PubMed ID: 27451409
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a "Tail Switching" Strategy on a Piperazinyl Azetidine Skeleton.
Chen Z; Mori W; Deng X; Cheng R; Ogasawara D; Zhang G; Schafroth MA; Dahl K; Fu H; Hatori A; Shao T; Zhang Y; Yamasaki T; Zhang X; Rong J; Yu Q; Hu K; Fujinaga M; Xie L; Kumata K; Gou Y; Chen J; Gu S; Bao L; Wang L; Collier TL; Vasdev N; Shao Y; Ma JA; Cravatt BF; Fowler C; Josephson L; Zhang MR; Liang SH
J Med Chem; 2019 Apr; 62(7):3336-3353. PubMed ID: 30829483
[TBL] [Abstract][Full Text] [Related]
19. Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase.
Aaltonen N; Savinainen JR; Ribas CR; Rönkkö J; Kuusisto A; Korhonen J; Navia-Paldanius D; Häyrinen J; Takabe P; Käsnänen H; Pantsar T; Laitinen T; Lehtonen M; Pasonen-Seppänen S; Poso A; Nevalainen T; Laitinen JT
Chem Biol; 2013 Mar; 20(3):379-90. PubMed ID: 23521796
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Evaluation of (4 R)-1-{3-[2-(
Hattori Y; Aoyama K; Maeda J; Arimura N; Takahashi Y; Sasaki M; Fujinaga M; Seki C; Nagai Y; Kawamura K; Yamasaki T; Zhang MR; Higuchi M; Koike T
J Med Chem; 2019 Mar; 62(5):2362-2375. PubMed ID: 30753069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
